Sobrera Pharma
PrivateLast Round
VC Round
Feb 5, 2026
Total Funding Raised
$3.35M
Company Overview
Sobrera Pharma operates in Healthcare & Life Sciences and is based in Gothenburg. Its latest recorded funding round was a VC Round in February 2026.
Sobrera Pharma is a biopharmaceutical company developing new treatments for patients with addiction disorders, with an initial focus on a therapy for Alcohol Use Disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sobrera Pharma Comparables
Compare Sobrera Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kinnov Therapeutics | 88% | |
| DemeRx, Inc. | 84% | |
| Baseline Therapeutics | 82% |
For institutional investors. Book with your work email.
Sobrera Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 5, 2026 | ||||
| Private Equity | Dec 31, 2020 |
For institutional investors. Book with your work email.
Sobrera Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Private Equity |
| Byggmastare Anders J Ahlstrom Holding | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 67% MoM.
- Oct 18, 2024
Monthly visitors grew 2919% MoM, from 53 to 1.6K.
For institutional investors. Book with your work email.
Sobrera Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sobrera Pharma's valuation, stock price, and market status.
Is Sobrera Pharma a public or private company?
Sobrera Pharma is a private company.
What is the current stock price of Sobrera Pharma?
Sobrera Pharma is a private company, so its shares have no public market price. Caplight tracks Sobrera Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sobrera Pharma worth (valuation)?
Valuation information for Sobrera Pharma is not publicly available.
Can I buy Sobrera Pharma stock?
Sobrera Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sobrera Pharma's last funding round?
Sobrera Pharma's most recent funding round was VC Round on February 5, 2026.
Who are the main investors in Sobrera Pharma?
Key investors in Sobrera Pharma include Vasa Angels I, Byggmastare Anders J Ahlstrom Holding.
Will Sobrera Pharma IPO soon?
No public IPO plans have been announced for Sobrera Pharma.
How can I track Sobrera Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Sobrera Pharma's shares on secondary markets.